Wire Stories
BeiGene and EUSA Pharma Announce China NMPA Approval of QARZIBA� (Dinutuximab Beta) for Patients with High-Risk Neuroblastoma
CAMBRIDGE, Mass. & BEIJING & HEMEL HEMPSTEAD, England–(BUSINESS WIRE)–$BGNE #BTKi–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160) and EUSA Pharma (UK), Ltd. today announced...